The gross margin series shows a sharp, non-linear collapse rather than gradual compression, consistent with OSB and lumber prices retreating faster than log and fiber costs can adjust. Against its own 2024-2025 range of roughly 25-33% in profitable quarters, the current negative readings indicate the spread between delivered log costs and finished product prices has inverted. This may imply that the reported 2026Q3 rebound to 27.0% is a timing-driven recovery rather than evidence of a durable margin floor, and investors should monitor whether it persists.

Negative ROIC across the most recent quarters indicates that invested capital is not earning its cost of capital, a pattern that is structurally concerning for a capital-intensive manufacturer. The 2025Q4 ROE figure is magnified by the shrinking equity base, which the balance sheet data shows fell from $7.2B to $5.5B, so part of the ratio deterioration reflects denominator effects from impairments rather than operating performance alone. The question for analysts is whether the asset base is being written down to a level where mid-cycle returns can recover, which the current data does not resolve.

With total debt near $522M against roughly $5.5B of equity, the company's balance sheet appears far less stretched than its operating losses might suggest. Interest coverage ratios are negative or unavailable in several quarters because EBIT is negative, so the metric carries little analytical weight right now and should not be read as a sign of debt service stress. The more relevant leverage question is whether impairment-driven equity erosion could reduce the cushion faster than debt is repaid, a risk that warrants continued monitoring.

The lengthening of days inventory outstanding during the downturn suggests finished goods are accumulating faster than they can be sold at acceptable prices, a dynamic that can force further net realizable value adjustments. Relative to its own 2024-2025 cycle of roughly 40-63 days, the 2026Q1 spike appears to reflect a deliberate or forced inventory build rather than normal seasonality. The partial recovery to 50 days is encouraging but still above the historical baseline, so investors should watch whether inventory normalizes without further price-driven write-downs.

Negative earnings render P/E uninformative, and the elevated EV/EBITDA reflects depressed trailing EBITDA rather than an expensive franchise; the forward EV/EBITDA of 35.72 suggests the market is already anticipating some earnings recovery. Trading near book value versus peers such as LPX at 3.11 times book indicates a meaningful discount, which may reflect skepticism about the durability of OSB pricing power or the book value itself given goodwill exposure. Investors should treat the valuation as a bet on normalized margins rather than on current earnings.